Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

Eye Cancer Clinical Trial

Official title:
Evaluation of Safety and Efficacy of Wrapping Orbital Implant by SclerFIX Product After Eye Enucleation

Status Completed

Clinical Trial Summary

The purpose of this open, monocenter pilot trial is to evaluate the tolerance of the SclerFIX product, an allograft of umbilical cord lining membrane, in the reinforcement of ocular implants in patients who underwent enucleation due to an eye malignant tumor resection.

Clinical Trial Description

As scleral graft is forbidden in France, it cannot be used for support of enucleation implants. This study investigational product, SclerFIX, was developed to substitute scleral grafts in those cases. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05236049
Study type	Interventional
Source	TBF Genie Tissulaire
Contact
Status	Completed
Phase	Phase 1
Start date	July 1, 2019
Completion date	April 27, 2022

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01151748` - Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma	Phase 2
Completed	`NCT00588640` - Study of D-Methadone in Patients With Chronic Pain	Phase 1/Phase 2
Completed	`NCT01135849` - B-Receptor Signaling in Cardiomyopathy	N/A
Completed	`NCT05853315` - BCC Excision Revisited
Active, not recruiting	`NCT01653080` - MRI in Diagnosing Solid Tumors of the Eye and Orbit	N/A
Completed	`NCT00020267` - Vaccine Therapy in Treating Patients With Metastatic Cancer	Phase 1
Completed	`NCT00601744` - Social-Psychological Aspects of Orbital Exenteration	N/A
Completed	`NCT01072253` - Quality of Life of Eye Amputated Patients in Denmark	N/A